NEW TREATMENT STRATEGIES AND DRUG DEVELOPMENT FOR THE ALZHEIMER’S DISEASE

Main Article Content

SHAHNAZ HAQUE

Abstract

The discussion in this research paper will explore the major reasons behind the Alzheimer’s disease and what kind of clinical treatments are available till now. This irreversible and progressive impairment of brain activities is a serious concern among the scientists worldwide for slowly destroying the behavioral, cognitive, and physical skills with eventually causing death. Statistical evidence is also presented to provide the significant evidence of the prevalence of the Alzheimer’s among the ageing populations worldwide. Hence it has been trying to focus on significant investments that should be made for the development of efficacious treatments for the AD patients. This research paper also covers the brief overview of the drug development and recent clinical trials to find out how the disease-modifying therapies (DMTs) are trying to improve the outcomes by changing the way of treating the Alzheimer’s patients, rather than depending on mere symptom management. It also emphasizes on building strong support group to assist the caregivers in overcoming the challenges.

Article Details

How to Cite
HAQUE, SHAHNAZ. NEW TREATMENT STRATEGIES AND DRUG DEVELOPMENT FOR THE ALZHEIMER’S DISEASE. International Journal of Recent Advances in Medical & Pharma Research, [S.l.], v. 2, n. 1, 2019. Available at: <https://medical.eurekajournals.com/index.php/IJRAMPR/article/view/53>. Date accessed: 21 nov. 2024.
Section
Articles